NSE: BALAMINES | BSE: 530999

Mid-range Performer

Download real time

1504.80 -1.50 (-0.10%)

38.15% Fall from 52W High

21,084 NSE+BSE Volume

NSE 12 Sep, 2025 3:31 PM (IST)

4,875.7

Market Cap

High in industry

1.2

Beta 1Year

Very High Volatility

Balaji Amines Ltd. share price target and research reports

Name: Latest research reports of Balaji Amines Ltd. authored by Edelweiss and published by - Trendlyne research reports.
Item: Balaji Amines Ltd.
Rating: 5
Author: Edelweiss

Latest analyst research reports with target prices and PDF download for BALAMINES, BSE:530999 Balaji Amines Ltd.

Balaji Amines Ltd.

29 Oct 2021

1504.80

-0.10%

Balaji Amines Ltd - Result Update Q2FY22

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines Ltd (BAL) witnessed strong top-line growth across standalone Amines business and subsidiary Balaji Specialty Chemicals (BSC).

Number of FII/FPI investors decreased from 112 to 105 in Jun 2025 qtr

Balaji Amines Ltd.

28 Jun 2021

1504.80

-0.10%

Balaji Amines Ltd

Buy: Balaji Amines Ltd.

Target

CD Equisearch

oxygen and logistical issues. Total Q4 sales volume stood at 24,878 mt, a 12.3% decline on a quarter-on-quarter quarter basis. Of this specialty chemicals...

Number of FII/FPI investors decreased from 112 to 105 in Jun 2025 qtr

Balaji Amines Ltd.

27 May 2021

1504.80

-0.10%

Balaji Amines Ltd | Q4FY21 Result Update

Buy: Balaji Amines Ltd.

Target

Edelweiss

Stellar quarter; new capacities to drive growth in FY22

Number of MF schemes decreased from 11 to 5 in Jun 2025 qtr

Balaji Amines Ltd.

11 Feb 2021

1504.80

-0.10%

Balaji Amines Ltd | Q3FY21 Result Update

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines (BAL) posted record high results in Q3FY21 consolidated revenue grew 72% YoY/39% QoQ to INR392cr (v/s est. 37% growth).

Number of MF schemes decreased from 11 to 5 in Jun 2025 qtr

Balaji Amines Ltd.

04 Nov 2020

1504.80

-0.10%

Balaji Amines | Q2FY21 Result Update

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines Ltd's (BAL) Q2FY21 consolidated revenue was at a record INR 282 crore, up 24% YoY/27% QoQ, and was 13% ahead of our estimates.

Number of MF schemes decreased from 11 to 5 in Jun 2025 qtr

Balaji Amines Ltd.

31 Aug 2020

1504.80

-0.10%

Balaji Amines Ltd.

Buy: Balaji Amines Ltd.

Target

CD Equisearch

Sub optimal capacity utilization in April and May operating at 70% and 80% respectively, due to Covid hampered volumes in the first quarter this fiscal which plummeted almost 18% sequentially on an absolute basis,...

Balaji Amines Ltd. has lost -33.61% in the last 1 Year

Balaji Amines Ltd.

16 Aug 2020

1504.80

-0.10%

Balaji Amines Ltd - Result Update Q1FY21

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines' (BAL) margin expanded in Q1FY21 on the back of a favourable product mix and benign raw material environment.

Balaji Amines Ltd. has gained 20.95% in the last 6 Months

Balaji Amines Ltd.

28 Feb 2020

1504.80

-0.10%

Balaji Amines Ltd.

Buy: Balaji Amines Ltd.

CD Equisearch

BAL started manufacturing acetonitrile from November with an installed capacity of 9000 tons. The domestic demand for acetonitrile is around 12000 tons annually. BAL is currently manufacturing ~3000 tons of...

Number of FII/FPI investors decreased from 112 to 105 in Jun 2025 qtr

Balaji Amines Ltd.

06 Feb 2020

1504.80

-0.10%

Balaji Amines Ltd - Result Update Q3FY20

Buy: Balaji Amines Ltd.

Edelweiss

Balaji Amines Ltd's (BAL) Q3FY20 results were broadly in-line with our expectations.

Number of MF schemes decreased from 11 to 5 in Jun 2025 qtr

Balaji Amines Ltd.

20 Jan 2020

1504.80

-0.10%

Balaji Amines (Update): All eyes on the subsidiary. Maintain BUY

Buy: Balaji Amines Ltd.

Target

HDFC Securities

Given the (1) Uncertainty in the ramp up of BSCPL (2) Muted earnings growth prospect (3) Declining return ratios (ROE: 16.1/15.1/13.5%, RoIC: 22.5/21.7/18.8% in FY20E/21E/22E), we prefer Alkyl Amines over Balaji in the Amines space. Maintain BUY with a TP of Rs 490 (13x Dec-21E EPS). We visited Balaji Amines and its subsidiarys Solapur facility, which was followed by an interaction with Mr. Ram Reddy, the companys Managing Director.

Number of FII/FPI investors decreased from 112 to 105 in Jun 2025 qtr

Is Balaji Amines Ltd. worth buying?

384 Votes:

Buy 83.85%

Sell 9.38%

Hold 6.77%